HopeStage
Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
14studies shown
Showing 1-12 of 14
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in New Zealand, ...

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, New Zealand, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Other study type icon
RecruitingACTRN12614000409673

MoodSwings: An Online Self Help Program for Bipolarity

The registry describes this research topic: “MoodSwings: An Online Self Help Program for bipolarity”. This is an interventional study.

Remote / online
Why is this study shown?

This study is directly about Bipolarity.

BipolarityOtherFrom 21 Years to 65 Years
Countries
United States, Australia
Sponsor
University of Melbourne
Condition
Bipolarity
Drug study icon
RecruitingACTRN12625000942459

A crossover study to investigate the safety, tolerability, pharmacokinetics, relative bioavailability, and pharmacodynamics of single doses of Katamine immediate release (KET-IR) and Ketamine abuse deterrent (KET-AD) oral ketamine capsules in healthy volunteers.

The registry lists this study as recruiting. Study locations are listed in Australia.

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 55 Years
Countries
Australia
Sponsor
Novotech (Australia) Pty Limited
Condition
Bipolarity
Drug study icon
RecruitingACTRN12620000703909

CADET candesartan study for depression in bipolarity: a study

The registry lists this study as recruiting. Study locations are listed in Australia.

In Australia
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to No limit
Countries
Australia
Sponsor
Deakin University
Condition
Bipolarity, Depression
Other study type icon
RecruitingACTRN12618001151224

Testing a well-being group program to prevent relapse for individuals with mood disorders

The registry describes this research topic: “Testing a well-being group program to prevent relapse for individuals with mood disorders”. This is an interventional study.

In Australia
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOtherFrom 18 Years to No limit
Countries
Australia
Sponsor
Quincy Wong
Condition
Bipolarity, Depression
Drug study icon
RecruitingACTRN12624000789561

The Kite study: Examining the Effectiveness of Ketamine for Adults with Depression in bipolarity

The registry describes this research topic: “The Kite Trial: Examining the Effectiveness of Ketamine for Adults with Bipolar Depression”. This is an interventional study.

In Australia
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to No limit
Countries
Australia
Sponsor
The University of Melbourne
Condition
Bipolarity, Depression
Other study type icon
RecruitingACTRN12626000685314

IDENTIFying the risk of recurrent and chronic Youth Depression (IDENTIFYD): A prospective longitudinal cohort study in help seeking young people aged 15 - 25

The registry lists this study as recruiting. Study locations are listed in Australia.

In Australia
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, Suicidality, ...ObservationalA study where researchers collect information without assigning a treatment.From 15 Years to 25 Years
Countries
Australia
Sponsor
Orygen
Condition
Depression, Suicidality, ...
Drug study icon
RecruitingACTRN12624000017527

MELODY study: A 12-week controlled study of adjunctive melatonin or digital cognitive behavioural therapy for insomnia, or placebo to improve depressive symptoms in young adults with mood disorders

The registry lists this study as recruiting. Study locations are listed in Australia.

In Australia
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrugFrom 18 Years to 30 Years
Countries
Australia
Sponsor
The University of Sydney
Condition
Depression, Bipolarity
Behavioral study icon
RecruitingACTRN12624000195550

A hybrid controlled feasibility study of a self-management intervention “My Personal REcovery Plan” (MyPREP) for people with long term mental health conditions: The MyPREP study

The registry lists this study as recruiting. Study locations are listed in Australia.

In Australia
Why is this study shown?

This study includes Bipolarity among several conditions.

PTSD, Schizophrenia, ...BehavioralFrom 18 Years to No limit
Countries
Australia
Sponsor
The University of Sydney
Condition
PTSD, Schizophrenia, ...
Behavioral study icon
RecruitingACTRN12619000838112

The Actionable Intime Insights (AI2) Study: Implementing a digital model for timely and needs-based interventions in mental health services by applying algorithms to health care data

The registry lists this study as recruiting. Study locations are listed in Australia.

In Australia
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityBehavioralFrom 18 Years to No limit
Countries
Australia
Sponsor
Flinders University
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.